- Joined
- Aug 24, 2018
- Messages
- 1,694
- Reaction score
- 12,386
Liraglutide's (Saxenda/Victoza) patents have already expired so it's only a matter of time before more affordable generics will be available to the NHS etc. Then it will be generic semaglutides (Ozempic, Wegovy et al).I read elsewhere that both Eli Lilly and Novo Nordisk are reducing production of insulin in order to increase production to their obesity injectables. This is on the basis that tackling obesity will reduce the incidence of Type II diabetes as well as treating other conditions that go hand in hand with obesity such as hypotension, high cholesterol, inflamatory liver conditions etc. Obviously the injectables are more expensive than insulin, but in most developed countries with state-run health services their cost can probably be justified. Presumably in the longer term, insulin supplies will still be available where they are the appropriate option.
Here in the UK, the NHS plans to make injectables available to everyone who will benefit from them but this will take quite a few years, not least because of supply issues. I would expect the NHS to be able to negotiate very price-advantageous contracts which may make it a cheaper option than prescribing half a dozen other drugs to deal with a whole raft of individual health conditions. Sort out the obesity and other problems will largely sort themselves out.

When Will Liraglutide Be Generic? | Unbranded Saxenda
Liraglutide is available as brands Saxenda & Victoza at the moment, but there are questions as to when will liraglutide be generic. Read more.
